Advanced Oncotherapy Share Price | |
---|---|
Price | 1.925 |
Bid | 0.00 |
Ask | 0.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 1.925 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 542.57m |
Market Capitalisation | £10.44m |
Market Size | 15,000 |
52 Week High | 8.50 |
52 Week High Date | 15-May-2023 |
52 Week Low | 1.875 |
52 Week Low Date | 28-Jun-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -0.249676 |
Earnings | -7.71 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
|
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
30-Dec-22 | 29-Dec-22 | Buy | Michael Bradfield held the position of Non-Executive Director at the time of this trade.Michael Bradfield | 13.21 | GBX | 250,000 | 8,354,240 |
30-Dec-22 | 29-Dec-22 | Buy | Michael Bradfield held the position of Non-Executive Director at the time of this trade.Michael Bradfield | 13.21 | GBX | 50,000 | 8,354,240 |
30-Dec-22 | 29-Dec-22 | Buy | Michael Bradfield held the position of Non-Executive Director at the time of this trade.Michael Bradfield | 12.97 | GBX | 100,000 | 8,354,240 |
30-Dec-22 | 29-Dec-22 | Buy | Michael Bradfield held the position of Non-Executive Director at the time of this trade.Michael Bradfield | 13.21 | GBX | 100,000 | 8,354,240 |
29-Dec-22 | 28-Dec-22 | Buy | Steve Myers OBE held the position of Non-Executive Director at the time of this trade.Steve Myers OBE | 12.50 | GBX | 70,000 | 1,193,902 |
A specialist developer and provider of the next generation of Proton beam therapy systems in the Proton therapy market.